Evrofarma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	3.32	0.66	1.44	0.25	3.11
Cash & Short-Term Investments	3.32	0.66	1.44	0.25	3.11
Cash Growth	405.94%	-54.28%	477.11%	-91.99%	2832.07%
Receivables	7.37	9.17	11.72	13.69	12.15
Inventory	7.11	6.52	5.56	3.07	3.57
Other Current Assets	-	-0	-	-	-
Total Current Assets	17.8	16.34	18.71	17.01	18.83
Property, Plant & Equipment	24.66	25.57	24.95	24.41	22.46
Long-Term Investments	0.22	0.01	0.06	0.04	0.04
Other Intangible Assets	0.13	0.05	0.06	0.1	0.13
Long-Term Accounts Receivable	0.03	0.33	0.03	0.03	0.02
Other Long-Term Assets	5.4	5.06	5.01	4.94	4.9
Total Assets	48.24	47.36	48.81	46.52	46.38
Accounts Payable	6.12	2.39	4.45	3.44	2.94
Accrued Expenses	-	0.5	0.45	0.87	0.32
Short-Term Debt	11.59	3.9	2.44	0.72	1.92
Current Portion of Long-Term Debt	-	3.08	2.71	2.5	2.63
Current Portion of Leases	0.07	0.04	0.04	0.03	0.02
Current Income Taxes Payable	0.49	0.4	0.11	-	0.02
Other Current Liabilities	-	2.73	2.48	2.64	2.85
Total Current Liabilities	18.26	13.04	12.67	10.2	10.71
Long-Term Debt	5.16	12.45	16.13	18.05	16.63
Long-Term Leases	0.14	0.07	0.06	0.01	0.01
Long-Term Unearned Revenue	5.73	4.43	4.69	4.42	4.82
Pension & Post-Retirement Benefits	0.08	0.07	0.05	0.05	0.05
Long-Term Deferred Tax Liabilities	1.04	1.08	1.18	1.18	1.19
Other Long-Term Liabilities	-0	-	-0	-	-
Total Liabilities	30.41	31.13	34.79	33.92	33.42
Common Stock	5.74	5.74	12.03	12.03	12.03
Additional Paid-In Capital	-	-	0.94	0.94	0.94
Retained Earnings	8.46	7.42	-1.49	-0.38	-0.01
Comprehensive Income & Other	3.62	3.06	2.55	0.02	-
Shareholders' Equity	17.83	16.23	14.03	12.61	12.96
Total Liabilities & Equity	48.24	47.36	48.81	46.52	46.38
Total Debt	16.95	19.53	21.38	21.31	21.22
Net Cash (Debt)	-13.63	-18.87	-19.94	-21.06	-18.11
Net Cash Per Share	-	-1.38	-1.46	-1.54	-1.32
Filing Date Shares Outstanding	-	13.67	13.67	13.67	13.67
Total Common Shares Outstanding	-	13.67	13.67	13.67	13.67
Working Capital	-0.46	3.3	6.04	6.81	8.12
Book Value Per Share	-	1.19	1.03	0.92	0.95
Tangible Book Value	17.69	16.18	13.97	12.51	12.83
Tangible Book Value Per Share	-	1.18	1.02	0.91	0.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.